Retiring Chemicalize Pro Services, Transitioning to Modern Solutions
Retiring Chemicalize Pro on December 31st, 2025, moving to more modern solutions.
CertaraNovember 26, 2025
Certara and ANVISA Partner to Launch eCTD 4.0 Submissions of Drug Applications in Brazil Through GlobalSubmit™ software
Certara and ANVISA have joined forces to enable eCTD 4.0 submissions in Brazil using GlobalSubmit™…
CertaraNovember 13, 2025
Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs
Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…
CertaraNovember 12, 2025
Java version requirement plans for Chemaxon products
Find the planned timeline for Java version requirements of Chemaxon products from 2025 to 2030.
CertaraNovember 11, 2025
Certara Joins Veeva AI Partner Program to Simplify and Expedite Regulatory Submissions for Life Sciences
Certara joins the Veeva AI Partner Program to integrate CoAuthor™ generative AI with Veeva RIM,…
CertaraOctober 21, 2025
Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science
Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…
CertaraSeptember 22, 2025
Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC
Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…
CertaraSeptember 17, 2025
Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool
RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraSeptember 17, 2025
Marvin JS End-of-Life and Transition Notice
Marvin JS, Chemaxon's web-based chemical drawing tool, will be retired on December 31, 2027. We…
CertaraSeptember 16, 2025
Certara Releases Environmental, Social and Governance Report
The report highlights a commitment to sustainability and corporate responsibilities. RADNOR, Pa. – August 26,…
CertaraAugust 26, 2025
